BioSpace News Archive

Viracta Therapeutics, Inc., a clinical-stage drug development company advancing innovative approaches to treat viral-associated cancers and other serious diseases, announced the formation of its inaugural Scientific Advisory Board.

Thomson Reuters recently announced their list of the top 100 most diverse and inclusive organizations. In the top 50 of the list there are 10 biopharma and medical device companies. Let’s take a look.

Bluechiip Ltd (ASX:BCT) provides the Company’s Annual Report to shareholders.

TCT18: New Five-Year Data with CoreValve TAVR System Suggests Durability Over Time, While Complete Results from the SURTAVI Trial Show Benefits of TAVR in Intermediate Risk Patients

Company Introduces Non-mydriatic Ophthalmic Camera

Company’s OmniVerita Designed to Enable Early Detection and Monitoring of Cancer

TransPerfect Life Sciences, a leading provider of services and technologies to support global product development for the life sciences industry, today announced a strategic partnership with Arondor.

COPIKTRA is a Dual Inhibitor Approved for Treatment of Adult Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Relapsed or Refractory Follicular Lymphoma

Acadia Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced two executive appointments: Robert Kaper, M.D., has joined ACADIA as Senior Vice President, Global Head of Medical Affairs, and Eliseo Salinas, M.D., M.Sc., has joined the company as Senior Vice President, Chief Scientific Officer and Head of External Innovation

Phillips-Medisize, a Molex company, an end-to-end provider of innovation, development and manufacturing solutions to the pharmaceutical, diagnostics and medical device industries announces enhanced capabilities which provide for compelling and unique ways of partnering with customers.